Chapter 10 : Mucosal Immunity to

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Mucosal Immunity to , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817176/9781555815394_Chap10-1.gif /docserver/preview/fulltext/10.1128/9781555817176/9781555815394_Chap10-2.gif


Prior to the human immunodeficiency virus (HIV) epidemic, host defense against at mucosal sites was largely considered one-dimensional. This chapter is divided into in-depth reviews of host defense mechanisms against oral, vaginal, and Gastrointestinal (GI) candidiasis, with emphasis on the uniqueness of the responses at each site. Then it has a short discussion of the emerging role of mucosal biofilms in pathogenesis and host defense. The chapter concludes with suggested future directions for the field of mucosal immunity and candidiasis. Oropharyngeal candidiasis (OPC) encompasses infections of the hard and soft palate, tongue, buccal mucosa, and floor of the mouth and can present as reddened patches (erythematous) or white curdlike lesions (pseudomembranous). Interestingly, highly active antiretroviral therapy (HAART) has reduced the incidence of OPC. Polymorphonuclear cells (PMNs) are considered to play a role in innate defenses against OPC because neutropenic cancer patients are susceptible to disease. Another form of oral candidiasis is -associated denture stomatitis (DS). is the most common cause of DS and can readily form biofilms on denture material. The most recent data on host defense against GI candidiasis involve understanding the role of dendritic cells (DCs) in directing both local and systemic adaptive immunity. Vulvovaginal candidiasis (VVC) affects a significant number of women, predominantly in their reproductive years.

Citation: Fidel, Jr. P, Noverr M. 2012. Mucosal Immunity to , p 137-154. In Calderone R, Clancy C (ed), and Candidiasis, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817176.ch10
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Allen, C. M.,, and F. M. Beck. 1987. Differences in mucosal reaction related to Candida albicans isolates. J. Oral Pathol. 16: 8993.
2. Allen, C. M.,, A. Saffer,, R. K. Meister,, F. M. Beck, and, S. Bradway. 1994. Comparison of a lesion-inducing isolate and a non-lesional isolate of Candida albicans in an immunosuppressed rat model of oral candidiasis. J. Oral Pathol. Med. 23: 133139.
3. Anaissie, E. J.,, and G. P. Bodey. 1990. Fungal infections in patients with cancer. Pharmacotherapy 10: 164S–169S.
4. Aujla, S. J.,, P. J. Dubin, and, J. K. Kolls. 2007. Th17 cells and mucosal host defense. Semin. Immunol. 19: 377382.
5. Babula, O.,, G. Lazdane,, J. Kroica,, I. M. Linhares,, W. J. Ledger, and, S. S. Witkin. 2005. Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 40: 12581262.
6. Baillie, G. S.,, and L. J. Douglas. 2000. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J. Antimicrob. Chemother. 46: 397403.
7. Balish, E.,, M. J. Balish,, C. A. Salkowski,, K. W. Lee, and, K. F. Bartizal. 1984. Colonization of congenitally athymic, gnotobiotic mice by Candida albicans. Appl. Environ. Microbiol. 47: 647652.
8. Balish, E.,, and H. Filutowicz. 1991. Serum antibody response of gnotobiotic athymic and euthymic mice following alimentary tract colonization and infection with Candida albicans. Can. J. Microbiol. 37: 204210.
9. Balish, E.,, J. Jensen,, T. Warner,, J. Brekke, and, B. Leonard. 1993. Mucosal and disseminated candidiasis in gnoto-biotic SCID mice. J. Med. Vet. Mycol. 31: 143154.
10. Balish, E.,, F. A. Vazquez-Torres,, J. Jones-Carson,, R. D. Wagner, and, T. Warner. 1996. Importance of β 2microglobulin in murine resistance to mucosal and systemic candidiasis. Infect. Immun. 64: 50925097.
11. Balish, E.,, R. D. Wagner,, A. Vazquez-Torres,, J. Jones-Carson,, C. Pierson, and, T. Warner. 1999. Mucosal and systemic candidiasis in IL-8Rh-/- BALB/c mice. J. Leukoc. Biol. 66: 144150.
12. Balish, E.,, T. Warner,, C. J. Pierson,, D. M. Bock, and, R. D. Wagner. 2001. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 39: 261268.
13. Balish, E.,, T. F. Warner,, P. J. Nicholas,, E. E. Paulling,, C. Westwater, and, D. A. Schofield. 2005. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect. Immun. 73: 13131320.
14. Barousse, M.,, B. J. Van Der Pol,, D. Fortenberry,, D. Orr, and, P. L. Fidel, Jr. 2004. Vaginal yeast colonization, prevalence of vaginitis, and associated local immunity in adolescents. Sex. Transm. Infect. 80: 4853.
15. Barousse, M. M.,, T. Espinosa,, K. Dunlap, and, P. L. Fidel, Jr. 2005. Vaginal epithelial cell anti- Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect. Immun. 73: 77657767.
16. Barousse, M. M.,, C. Steele,, K. Dunlap,, T. Espinosa,, D. Boikov,, J. D. Sobel, and, P. L. Fidel, Jr. 2001. Growth inhibition of Candida albicans by human vaginal epithelial cells. J. Infect. Dis. 184: 14891493.
17. Bassetti, M.,, E. Righi,, A. Costa,, R. Fasce,, M. P. Molinari,, R. Rosso,, F. B. Pallavicini, and, C. Viscoli. 2006. Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect. Dis. 6: 21.
18. Beno, D. W. A.,, and H. L. Mathews. 1992. Growth inhibition of Candida albicans by interleukin-2-activated splenocytes. Infect. Immun. 60: 853863.
19. Beno, D. W. A.,, A. G. Stover, and, H. L. Mathews. 1995. Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J. Immunol. 154: 52735281.
20. Bilhan, H.,, T. Sulun,, G. Erkose,, H. Kurt,, Z. Erturan,, O. Kutay, and, T. Bilgin. 2009. The role of Candida albicans hyphae and Lactobacillus in denture-related stomatitis. Clin. Oral Investig. 13: 363368.
21. Black, C. A.,, F. M. Eyers,, M. L. Dunkley,, R. L. Clancy, and, K. W. Beagley. 1999. Major histocompatibility haplo-type does not impact the course of experimentally induced murine vaginal candidiasis. Lab. Anim. Sci. 49: 668672.
22. Black, C. A.,, F. M. Eyers,, A. Russell,, M. L. Dunkley,, R. L. Clancy, and, K. W. Beagley. 1998. Acute neutropenia decreases inflammation associated with murine vaginal candidiasis but has no effect on the course of infection. Infect. Immun. 66: 12731275.
23. Black, C. A.,, F. M. Eyers,, A. Russell,, M. L. Dunkley,, R. L. Clancy, and, K. W. Beagley. 1999. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes. J. Reprod. Immunol. 45: 118.
24. Blankenship, J. R.,, and A. P. Mitchell. 2006. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9: 588594.
25. Bonifazi, P.,, T. Zelante,, C. D’Angelo,, A. De Luca,, S. Moretti,, S. Bozza,, K. Perruccio,, R. G. Iannitti,, G. Giovannini,, C. Volpi,, F. Fallarino,, P. Puccetti, and, L. Romani. 2009. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2: 362374.
26. Budtz-Jorgensen, E.,, A. Stenderup, and, M. Grabowski. 1975. An epidemiologic study of yeasts in elderly denture wearers. Commun. Dent. Oral 3: 115119.
27. Burns, D. N.,, R. Tuomala,, B. H. Chang,, R. Hershow,, H. Minkoff,, E. Rodriquez,, C. Zorrilla,, H. Hammill, and, J. Regan. 1997. Vaginal colonization or infection with Candida albicans in human immunodeficiency virus-infected women during pregnancy and during postpartum period. Clin. Infect. Dis. 24: 201210.
28. Cain, J. A.,, and G. S. Deepe, Jr. 2000. Interleukin-12 neutralization alters lung inflammation and leukocyte expression of CD80, CD86, and major histocompatibility complex class II in mice infected with Histoplasma capsulatum. Infect. Immun. 68: 20692076.
29. Calderone, R. A.,, and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9: 327335.
30. Cameron, A. L.,, B. Kirby,, W. Fei, and, C. E. M. Griffiths. 2002. Natural killer and natural killer-T cells in psoriasis. Arch. Dermatol. Res. 294: 363369.
31. Cantorna, M.,, D. Mook, and, E. Balish. 1990. Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidiasis. Infect. Immun. 58: 38133815.
32. Cantorna, M. T.,, and C. Balish. 1991. Acquired immunity to systemic candidiasis in immunodeficient mice. J. Infect. Dis. 164: 936943.
33. Cantorna, M. T.,, and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58: 10931100.
34. Reference deleted.
35. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63: 42114218.
36. Cassone, A.,, M. Boccanera,, D. A. Adriani,, G. Santoni, and, F. De Bernardis. 1995. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal infection. Infect. Immun. 63: 26192624.
37. Cassone, A.,, F. De Bernardis,, A. Torosantucci,, E. Tacconelli,, M. Tumbarello, and, R. Cauda. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis. 180: 448453.
38. Castro, G.,, and R. Martinez. 2009. Relationship between serum and saliva antibodies to Candida and isolation of Candida species from the mucosa of HIV-infected individuals. Mycoses 52: 246250.
39. Cenci, E.,, A. Mencacci,, G. Del Sero,, A. Bacci,, C. Montagnoli,, C. F. D’Ostiani,, P. Mosci,, M. Bachmann,, F. Bistoni,, M. Kopf, and, L. Romani. 1999. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J. Infect. Dis. 180: 19571968.
40. Cenci, E.,, A. Mencacci,, R. Spaccapelo,, L. Tonnetti,, P. Mosci,, K. H. Enssle,, P. Puccetti,, L. Romani, and, F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171: 12791288.
41. Chakir, J.,, L. Cote,, C. Coulombe, and, N. Deslauriers. 1994. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol. Immunol. 9: 8894.
42. Chandra, J.,, D. M. Kuhn,, P. K. Mukherjee,, L. L. Hoyer,, T. McCormick, and, M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 53855394.
43. Reference deleted.
44. Clark, R. A.,, S. A. Blakley,, J. Rice, and, W. Brandon. 1995. Predictors of HIV progression in women. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9: 4350.
45. Concia, E.,, A. M. Azzini, and, M. Conti. 2009. Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients. Drugs 69( Suppl. 1) : 514.
46. Conti, H. R.,, F. Shen,, N. Nayyar,, E. Stocum,, J. N. Sun,, M. J. Lindemann,, A. W. Ho,, J. H. Hai,, J. J. Yu,, J. W. Jung,, S. G. Filler,, P. Masso-Welch,, M. Edgerton, and, S. L. Gaffen. 2009. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206: 299311.
47. Coogan, M. M.,, S. P. Sweet, and, S. J. Challacombe. 1994. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect. Immun. 62: 892896.
48. Corrigan, E. M.,, R. L. Clancy,, M. L. Dunkley,, F. M. Eyers, and, K. W. Beagley. 1998. Cellular immunity in recurrent vulvovaginal candidiasis. Clin. Exp. Immunol. 111: 574578.
49. Croxtall, J. D.,, D. W. Gilroy,, E. Solito,, Q. Choudhury,, B. J. Ward,, J. C. Buckingham, and, R. J. Flower. 2003. Attenuation of glucocorticoid functions in an Anx-A1 -/-cell line. Biochem. J. 371: 927935.
50. Crump, J. A.,, and P. J. Collignon. 2000. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 19: 18.
51. Daniluk, T.,, G. Tokajuk,, W. Stokowska,, K. Fiedoruk,, M. Sciepuk,, M. L. Zaremba,, D. Rozkiewicz,, D. Cylwik-Rokicka,, B. A. Kedra,, I. Anielska,, M. Gorska, and, B. R. Kedra. 2006. Occurrence rate of oral Candida albicans in denture wearer patients. Adv. Med. Sci. 51 (Suppl. 1):77–80.
52. Davis, S. L.,, J. A. Vazquez, and, P. S. McKinnon. 2007. Epidemiology, risk factors, and outcomes of Candida albicans versus non- albicans candidemia in nonneutropenic patients. Ann. Pharmacother. 41: 568573.
53. De Bernardis, F.,, M. Boccanera,, D. Adriana,, E. Spreghini,, G. Santoni, and, A. Cassone. 1997. Protective role of anti-mannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65: 33993405.
54. De Bernardis, F.,, M. Boccanera,, D. Adriani,, A. Girolamo, and, A. Cassone. 2002. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis. Infect. Immun. 70: 27252729.
55. De Bernardis, F.,, G. Santoni,, M. Boccanera,, E. Spreghini,, D. Adriani,, L. Morelli, and, A. Cassone. 2000. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans. Infect. Immun. 68: 32973304.
56. Del Sero, G.,, A. Mencacci,, E. Cenci,, C. F. d’Ostiani,, C. Montagnoli,, A. Bacci,, P. Mosci,, M. Kopf, and, L. Romani. 1999. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect. 1: 11691180.
57. De Repentigny, L.,, F. Aumont,, J. Ripeau,, M. Fiorillo,, D. Kay,, Z. Hanna, and, P. Jolicoeur. 2002. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J. Infect. Dis. 185: 11031114.
58. Deslauriers, N.,, L. Cote,, S. Montplaisir, and, L. De Repentigny. 1997. Oral carriage of Candida albicans in murine AIDS. Infect. Immun. 65: 661667.
59. Diaz, L. S.,, H. Foster,, M. R. Stone,, S. Fujimura,, D. A. Relman, and, J. A. Levy. 2005. VCAM-1 expression on CD8+ cells correlates with enhanced anti-HIV suppressing activity. J. Immunol. 174: 15741579.
60. Dominic, R. M.,, S. Shenoy, and, S. Baliga. 2007. Candida biofilms in medical devices: evolving trends. Kathmandu Univ. Med. J. 5: 431436.
61. Domino, S. E.,, E. A. Hurd,, K. A. Thomsson,, D. M. Karnak,, J. M. Holmén Larsson,, E. Thomsson,, M. Bäckström, and, G. C. Hansson. 2009. Cervical mucins carry alpha(1,2) fucosylated glycans that partly protect from experimental vaginal candidiasis. Glycoconj. J. 26: 11251134.
62. Donders, G. G.,, O. Babula,, G. Bellen,, I. M. Linhares, and, S. S. Witkin. 2008. Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG 115: 12251231.
63. Dongari-Bagtzoglou, A.,, and H. Kashleva. 2003. Candida albicans triggers interleukin-8 by oral epithelial cells. Microb. Pathog. 34: 169177.
64. Dongari-Bagtzoglou, A.,, and H. Kashleva. 2003. Granulocyte-macrophage colony-stimulating factor responses of oral epithelial cells to Candida albicans. Oral Microbiol. Immunol. 18: 165170.
65. Dongari-Bagtzoglou, A.,, H. Kashleva,, P. Dwivedi,, P. Diaz, and, J. Vasilakos. 2009. Characterization of mucosal Candida albicans biofilms. PloS One 4: e7967.
66. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11: 3036.
67. Duerr, A.,, M. F. Sierra,, J. Feldman,, L. M. Clarke,, I. Ehlich, and, J. Dehovitz. 1997. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet. Gynecol. 90: 252256.
68. Elahi, S.,, G. Pang,, R. Clancy, and, R. B. Ashman. 2000. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect. Immun. 68: 57715777.
69. El Hed, A.,, A. Khaitan,, L. Kozhaya,, N. Manel,, D. Daskalakis,, W. Borkowsky,, F. Valentine,, D. R. Littman, and, D. Unutmaz. 2010. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 201: 843854.
70. Farah, C. S.,, S. Elahi,, G. Pang,, T. Gotjamanos,, G. J. Seymour,, R. L. Clancy, and, R. B. Ashman. 2001. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis. Infect. Immun. 69: 61106118.
71. Farah, C. S.,, T. Gotjamanos,, G. J. Seymour, and, R. B. Ashman. 2002. Cytokines in the oral mucosa of mice infected with Candida albicans. Oral Microbiol. Immunol. 17: 375378.
72. Feng, Z.,, B. Jiang,, J. Chandra,, M. Ghannoum,, S. Nelson, and, A. Weinberg. 2005. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J. Dent. Res. 84: 445450.
73. Ferwerda, B.,, G. Ferwerda,, T. S. Plantinga,, J. A. Willment,, A. B. van Spriel,, H. Venselaar,, C. C. Elbers,, M. D. Johnson,, A. Cambi,, C. Huysamen,, L. Jacobs,, T. Jansen,, K. Verheijen,, L. Masthoff,, S. A. Morre,, G. Vriend,, D. L. Williams,, J. R. Perfect,, L. A. Joosten,, C. Wijmenga,, J. W. van der Meer,, G. J. Adema,, B. J. Kullberg,, G. D. Brown, and, M. G. Netea. 2009. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361: 17981801.
74. Fidel, P. L. 2006. Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv. Dent. Res. 19: 8084.
75. Fidel, P. L., Jr. 2004. History and new insights into host defense against vaginal candidiasis. Trends Microbiol. 12: 220227.
76. Fidel, P. L.,, Jr., M. Barousse,, T. Espinosa,, C. Camaratti,, M. Ficarra,, D. H. Martin,, A. J. Quayle, and, K. Dunlap. 2004. A live intravaginal Candida challenge in humans reveals new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect. Immun. 72: 29392946.
77. Fidel, P. L.,, Jr., J. L. Cutright, and, J. D. Sobel. 1995. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect. Immun. 63: 41914194.
78. Fidel, P. L.,, Jr., K. A. Ginsburg,, J. L. Cutright,, N. A. Wolf,, D. Leaman,, K. Dunlap, and, J. D. Sobel. 1997. Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen. J. Infect. Dis. 176: 728739.
79. Fidel, P. L.,, Jr., W. Luo,, C. Steele,, J. Chabain,, M. Baker, and, F. L. Wormley. 1999. Analysis of vaginal cell populations during experimental vaginal candidiasis. Infect. Immun. 67: 31353140.
80. Fidel, P. L.,, Jr., M. E. Lynch,, D. H. Conaway,, L. Tait, and, J. D. Sobel. 1995. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun. 63: 547553.
81. Fidel, P. L.,, Jr., M. E. Lynch,, V. Redondo-Lopez,, J. D. Sobel, and, R. Robinson. 1993. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J. Infect. Dis. 168: 14581465.
82. Fidel, P. L.,, Jr., M. E. Lynch, and, J. D. Sobel. 1995. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect. Immun. 63: 24032408.
83. Fidel, P. L.,, Jr., M. E. Lynch, and, J. D. Sobel. 1994. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect. Immun. 62: 10321038.
84. Fidel, P. L.,, Jr., and J. D. Sobel. 1996. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin. Microbiol. Rev. 9: 335348.
85. Fidel, P. L.,, Jr., N. A. Wolf, and, M. A. KuKuruga. 1996. T lymphocytes in the murine vaginal mucosa are pheno-typically distinct from those in the periphery. Infect. Immun. 64: 37933799.
86. Fong, I. W.,, P. McCleary, and, S. Read. 1992. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am. J. Obstet. Gynecol. 166: 887890.
87. Frank, C. F.,, and M. K. Hostetter. 2007. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl. Res. 149: 211222.
88. Gebhardt, C.,, J. Németh,, P. Angel, and, J. Hess. 2006. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72: 16221631.
89. Giraldo, P. C.,, O. Babula,, A. K. Goncalves,, I. M. Lin-hares,, R. L. Amaral,, W. J. Ledger, and, S. S. Witkin. 2007. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet. Gynecol. 109: 11231128.
90. Goupil, M.,, E. Belanger Trudelle,, V. Dugas,, C. Racicot-Bergeron,, F. Aumont,, S. Senechal,, Z. Hanna,, P. Jolicoeur, and, L. De Repentigny. 2009. Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene. Infect. Immun. 77: 41364149.
91. Greenspan, D.,, E. Komaroff,, M. Redford,, J. A. Phelan,, M. Navazesh,, M. E. Alves,, H. Kamrath,, R. Mulligan,, C. E. Barr, and, J. S. Greenspan. 2000. Oral mucosal lesions and HIV viral load in the Women’s Interagency HIV Study (WIHS). J. Acquir. Immune Defic. Syndr. 25: 4450.
92. Gruber, A.,, C. Speth,, E. Lukasser-Vogl,, R. Zangerle,, M. Borg-von Zepelin,, M. P. Dierich, and, R. Wurzner. 1999. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology 41: 227234.
93. Han, Y.,, R. P. Morrison, and, J. E. Cutler. 1998. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66: 57715776.
94. Han, Y.,, M. H. Riesselman, and, J. E. Cutler. 2000. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68: 16491654.
95. Harriott, M. M.,, E. A. Lilly,, T. E. Rodriguez,, P. L. Fidel, Jr., and, M. C. Noverr. 2010. Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156( Pt. 12) : 36353644.
96. Hector, R. F.,, J. E. Domer, and, E. W. Carrow. 1982. Immune responses to Candida albicans in genetically distinct mice. Infect. Immun. 38: 10201028.
97. Hise, A. G.,, J. Tomalka,, S. Ganesan,, K. Patel,, B. A. Hall,, G. D. Brown, and, K. A. Fitzgerald. 2009. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 5: 487497.
98. Hladik, F.,, G. Lentz,, E. Delpit,, A. McElroy, and, M. J. McElrath. 1999. Coexpression of CCR5 and IL-2 in human genital but not blood cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J. Immunol. 163: 23062313.
99. Hobbs, J. R.,, D. Briden,, F. Davidson,, M. Kahan, and, J. K. Oates. 1977. Immunological aspects of candidal vaginitis. Proc. R. Soc. Med. 70: 1114.
100. Ibraghimov, A. R.,, R. E. Sacco,, M. Sandor,, Z. Iakoubov, and, R. G. Lynch. 1995. Resident CD4+ αβ T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int. Immunol. 7: 17631769.
101. Iiai, T.,, H. Watanabe,, T. Suda,, H. Okamoto,, T. Abo, and, K. Hatakeyama. 2002. CD161+ T (NT) cells exist predominately in human intestinal epithelium as well as liver. Clin. Exp. Immunol. 129: 9298.
102. Imam, N.,, C. C. J. Carpenter,, K. H. Mayer,, A. Fisher,, M. Stein, and, S. B. Danforth. 1990. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am. J. Med. 89: 142146.
103. Inghirami, G.,, B. Y. Zhu,, L. Chess, and, D. M. Knowles. 1990. Flow cytometric and immunohistochemical characterization of the gamma/delta T-lymphocyte population in normal human lymphoid tissue and peripheral blood. Am. J. Pathol. 136: 357367.
104. Itohara, S.,, A. G. Farr,, J. J. Lafaille,, M. Bonneville,, Y. Takagaki,, W. Haas, and, S. Tonegawa. 1990. Homing of a gamma/delta thymocyte subset with homogenous T-cell receptors to mucosal epithelia. Nature 343: 754757.
105. Jensen, J.,, A. Vazquez-Torres, and, E. Balish. 1992. Poly(I · C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis. Infect. Immun. 60: 45494557.
106. Jensen, J.,, T. Warner, and, E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170: 900905.
107. Jensen, J.,, T. Warner, and, E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167: 912919.
108. Jensen, J.,, T. Warner,, C. Johnson, and, E. Balish. 1996. Oral immunization of mice against candidiasis. J. Infect. Dis. 174: 133140.
109. Johansson, E. L.,, A. Rudin,, L. Wassen, and, J. Holm-gren. 2000. Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 96: 272277.
110. Reference deleted.
111. Jones-Carson, J.,, A. Vazquez-Torres,, T. Warner, and, E. Balish. 2000. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect. Immun. 68: 23632365.
112. Kalo-Klein, A.,, and S. S. Witkin. 1989. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 161: 11321136.
113. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165: 11681175.
114. Kirkpatrick, C. H. 1984. Host factors in defense against fungal infections. Am. J. Med. 77: 112.
115. Kirkpatrick, C. H.,, J. W. Chandler, and, R. N. Schimke. 1970. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin. Exp. Immunol. 6: 375385.
116. Kirkpatrick, C. H.,, R. R. Rich, and, J. E. Bennett. 1971. Chronic mucocutaneous candidiasis: model building in cellular immunity. Ann. Intern. Med. 74: 955978.
117. Kirkpatrick, C. H.,, and P. G. Sohnle. 1981. Chronic mucocutaneous candidiasis, p. 495–514. In B. Safai and, R. A. Good (ed.), Immunodermatology. Plenum Press, New York, NY.
118. Klein, R. S.,, C. A. Harris,, C. B. Small,, B. Moll,, M. Lesser, and, G. H. Friedland. 1984. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med. 311: 354357.
119. Kleinegger, C. L.,, S. R. Lockhart,, K. Vargas, and, D. R. Soll. 1996. Frequency, intensity, species, and strains of oral Candida vary as a function of host age. J. Clin. Microbiol. 34: 22462254.
120. Koh, A. Y.,, J. R. Kohler,, K. T. Coggshall,, N. Van Rooijen, and, G. B. Pier. 2008. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 4: e35.
121. Kojic, E. M.,, and R. O. Darouiche. 2004. Candida infections of medical devices. Clin. Microbiol. Rev. 17: 255267.
122. Korn, T.,, E. Bettelli,, M. Oukka, and, V. K. Kuchroo. 2009. IL-17 and Th17 cells. Annu. Rev. Immunol. 27: 485517.
123. Kumar, R. K.,, Z. Yang,, S. Bilson,, S. Thliveris,, B. E. Cooke, and, C. L. Geczy. 2001. Dimeric S100A8 in human neutrophils is diminished after phagocytosis. J. Leukoc. Biol. 70: 5964.
124. Kunkl, A.,, L. Mortara,, M. T. Valle,, D. Fenoglio,, M. Paola,, A. M. Megiovanni,, A. Alessandrini,, G. Li Pira,, G. Mazzarello,, V. Del Bono,, A. Canessa,, D. Bassetti, and, F. Manca. 1998. Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons. J. Infect. Dis. 178: 488496.
125. LaFleur, M. D.,, C. A. Kumamoto, and, K. Lewis. 2006. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob. Agents Chemother. 50: 38393846.
126. LeBlanc, D. M.,, M. M. Barousse, and, P. L. Fidel, Jr. 2006. A role for dendritic cells in immunoregulation during experimental vaginal candidiasis. Infect. Immun. 74: 32133221.
127. Lee, H.,, A. Yu,, C. C. Johnson,, E. A. Lilly,, M. C. Noverr, and, P. L. Fidel, Jr. 17 February 2011. Fabrication of a multi-applicable removable intraoral denture system for rodent research. J. Oral Rehabil. doi:10.1111/j.1365-2842.2011.02206.x.
128. Lehrnbecher, T.,, C. Frank,, K. Engels,, S. Kriener,, A. H. Groll, and, D. Schwabe. 2010. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 61 :259–265.
129. Leigh, J. E.,, M. Barousse,, R. K. Swoboda,, T. Myers,, S. Hager,, N. A. Wolf,, J. L. Cutright,, J. Thompson,, J. D. Sobel, and, P. L. Fidel, Jr. 2001. Candida-specific systemic cell-mediated immune reactivities in HIV-infected persons with and without mucosal candidiaisis. J. Infect. Dis. 183: 277285.
130. Leigh, J. E.,, K. M. McNulty, and, P. L. Fidel, Jr. 2006. Characterization of the immune status of CD8 + T cells in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis. Clin. Vaccine Immunol. 13: 678683.
131. Leigh, J. E.,, C. Steele,, F. L. Wormley, Jr., and, P. L. Fidel, Jr. 2001. Salivary cytokine profiles in the immuno-competent individual with Candida-associated denture stomatitis. Oral Microbiol. Immunol. 17: 311314.
132. Leigh, J. E.,, C. Steele,, F. L. Wormley, Jr.,, W. Luo,, R. A. Clark,, W. R. Gallaher, and, P. L. Fidel, Jr. 1998. Th1/ Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19: 373380.
133. Lilly, E.,, D. J. Hart,, J. E. Leigh,, S. Hager,, K. M. McNulty,, D. E. Mercante, and, P. L. Fidel, Jr. 2004. Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis. J. Infect. Dis. 190: 605612.
134. Lilly, E. A.,, J. E. Leigh,, K. M. McNulty,, S. H. Joseph,, D. E. Mercante, and, P. L. Fidel, Jr. 2006. Chemokine receptor expression in HIV-positive persons with oropharyngeal candidiasis. Oral Dis. 12: 493499.
135. Lilly, E. A.,, J. Yano, and, P. L. Fidel, Jr. 2010. Annexin-A1 identified as the oral epithelial cell anti- Candida effector moiety. Mol. Oral Microbiol. 25: 293304.
136. Liu, N.,, Y. P. Zhang,, S. Han,, J. Pei,, L. Y. Xu,, P. Lu,, C. B. Shields, and, X. Xu. 2007. Annexin A1 reduces inflammatory reaction and tissue damage through inhibition of phospholipase A 2 activation in adult rats following spinal cord injury. J. Neuropathol. Exp. Neurol. 66: 932943.
137. Lynch, M. E.,, J. D. Sobel, and, P. L. Fidel, Jr. 1996. Role of antifingal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J. Med. Vet. Mycol. 34: 337339.
138. Macher, A. M. 1988. The pathology of AIDS. Public Health Rep. 103: 246254.
139. Mackewicz, C. E.,, B. K. Patterson,, S. A. Lee, and, J. A. Levy. 2000. CD8 + cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J. Gen. Virol. 81( Pt. 5) : 12611264.
140. Magee, D. M.,, and R. A. Cox. 1995. Roles of gamma interferon and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect. Immun. 63: 35143519.
141. Magill, S. S.,, S. M. Swoboda,, E. A. Johnson,, W. G. Merz,, R. K. Pelz,, P. A. Lipsett, and, C. W. Hendrix. 2006. The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. Diagn. Microbiol. Infect. Dis. 55: 293301.
142. Magill, S. S.,, S. M. Swoboda,, C. E. Shields,, E. A. Colantuoni,, A. W. Fothergill,, W. G. Merz,, P. A. Lipsett, and, C. W. Hendrix. 2009. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. Ann. Surg. 249: 657665.
143. Magliani, W.,, S. Conti,, F. DeBernardis,, M. Gerloni,, D. Bertolotti,, P. Mozzoni,, A. Cassone, and, L. Polonelli. 1997. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15: 155158.
144. Manzoni, P.,, M. Mostert,, M. L. Leonessa,, C. Priolo,, D. Farina,, C. Monetti,, M. A. Latino, and, G. Gomirato. 2006. Oral supplementation with Lactobacillus casei sub-species rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin. Infect. Dis. 42: 17351742.
145. Marquis, M.,, D. Lewandowski,, V. Dugas,, F. Aumont,, S. Senechal,, P. Jolicoeur,, Z. Hanna, and, L. De Repentigny. 2006. CD8 + T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Infect. Immun. 74: 23822391.
146. Mathur, S.,, G. Virella,, J. Koistinen,, E. O. Horger,, T. A. Mahvi, and, H. H. Fudenberg. 1977. Humoral immunity in vaginal candidiasis. Infect. Immun. 15: 287294.
147. McNulty, K. M.,, J. Plianrungsi,, J. E. Leigh,, D. E. Mercante, and, P. L. Fidel, Jr. 2005. Characterization of the CD8 + T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis. Infect. Immun. 73: 36593667.
148. Meiller, T. F.,, B. Hube,, L. Schild,, M. E. Shirtliff,, M. A. Scheper,, R. Winkler,, A. Ton, and, M. A. Jabra-Rizk. 2009. A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One 4: e5309.
149. Mendling, W.,, and U. Koldovsky. 1996. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Infect. Dis. Obstet. Gynecol. 4: 225231.
150. Milanese, M.,, L. Segat,, F. De Seta,, D. Pirulli,, A. Fabris,, M. Morgutti, and, S. Crovella. 2008. MBL2 genetic screening in patients with recurrent vaginal infections. Am. J. Reprod. Immunol. 59: 146151.
151. Millon, L.,, C. Drobacheff,, R. Piarroux,, M. Monod,, G. Reboux,, R. Laurent, and, D. Meillet. 2001. Longitudinal study of anti- Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 26: 137144.
152. Montagnoli, C.,, A. Bacci,, S. Bozza,, R. Gaziano,, P. Mosci,, A. H. Sharpe, and, L. Romani. 2002. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169: 62986308.
153. Myers, T. A.,, J. E. Leigh,, A. Arribas,, S. Hager,, R. A. Clark,, E. Lilly, and, P. L. Fidel, Jr. 2003. Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis. Infect. Immun. 71: 956963.
154. Nandi, D.,, and J. P. Allison. 1991. Phenotypic analysis and gamma/delta-T cell receptor repertoire of murine T cells associated with the vaginal epithelium. J. Immunol. 147: 17731778.
155. National Institutes of Health. 1999. SBIR/STTR Study and Control of Microbial Biofilms. PA-99-084. National Institutes of Health, Bethesda, MD.
156. Nawrot, U.,, K. Grzybek-Hryncewicz,, U. Zielska,, A. Czarny, and, J. Podwinska. 2000. The study of cell-mediated immune response in recurrent vulvovaginal candidiasis. FEMS Immunol. Med. Microbiol. 29: 8994.
157. Nett, J.,, L. Lincoln,, K. Marchillo,, R. Massey,, K. Holoyda,, B. Hoff,, M. VanHandel, and, D. Andes. 2007. Putative role of β-1,3 glucans in Candida albicans biofilm resistance. Antimicrob. Agents Chemother. 51: 510520.
158. Newman, S. L.,, and A. Holly. 2001. Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect. Immun. 69: 68136822.
159. Nielsen, H.,, K. D. Bentsen,, L. Hojtved,, E. H. Willemoes,, F. Scheutz,, M. Schiodt,, K. Stoltze, and, J. J. Pind-borg. 1994. Oral candidiasis and immune status of HIV-infected patients. J. Oral Pathol. Med. 23: 140–143.
160. Nobile, C. J.,, D. R. Andes,, J. E. Nett,, F. J. Smith,, F. Yue,, Q. T. Phan,, J. E. Edwards,, S. G. Filler, and, A. P. Mitchell. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2: e63.
161. Nomanbhoy, F.,, C. Steele,, J. Yano, and, P. L. Fidel, Jr. 2002. Vaginal and oral epithelial cell anti- Candida activity. Infect. Immun. 70: 70817088.
162. Nucci, M.,, and E. Anaissie. 2001. Revisiting the source of candidemia: skin or gut? Clin. Infect. Dis. 33: 19591967.
163. Odds, F. C. 1988. Candida and Candidosis, p. 104–110. University Park Press, Baltimore, MD.
164. Oliviera, M. A.,, L. P. Carvalho,, S. Gomes Mde,, O. Ba-cellar,, T. F. Barros, and, E. M. Carvalho. 2007. Microbiological and immunological features of oral candidiasis. Microbiol. Immunol. 51: 713719.
165. Olsen, I.,, and O. Bondevik. 1978. Experimental Candida-induced denture stomatitis in the Wistar rat. Scand. J. Dent. Res. 86: 392398.
166. Palella, F. J.,, Jr., K. M. Delaney,, A. C. Moorman,, M. O. Loveless,, J. Fuhrer,, G. A. Satten,, D. J. Aschman, and, S. D. Holmberg, and the HIV Outpatient Study Investigators. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338: 853860.
167. Parr, M. B.,, and E. L. Parr. 1991. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod. 44: 491498.
168. Pfaller, M. A.,, and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20: 133163.
169. Phelan, J. A.,, B. R. Salzman,, G. H. Friendland, and, R. S. Klein. 1987. Oral findings in patients with acquired immune deficiency syndrome. Oral Surg. 64: 5056.
170. Pietrella, D.,, A. Rachini,, A. Torosantucci,, P. Chiani,, A. J. Brown,, F. Bistoni,, P. Costantino,, P. Mosci,, C. d’Enfert,, R. Rappuoli,, A. Cassone, and, A. Vecchiarelli. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 28: 17171725.
171. Quinti, I.,, C. Palma,, E. C. Guerra,, M. J. Gomez,, I. Mezzaroma,, F. Aiuti, and, A. Cassone. 1991. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocyes of HIV-infected subjects. Clin. Exp. Immunol. 85: 18.
172. Rabeneck, L.,, M. M. Crane,, J. M. Risser,, C. E. Lacke, and, N. P. Wray. 1993. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J. Gen. Int. Med. 8: 59.
173. Rahman, D.,, M. Mistry,, S. Thavaraj,, S. J. Challacombe, and, J. R. Naglik. 2007. Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions. Microbes Infect. 9: 615622.
174. Ramage, G.,, J. P. Martinez, and, J. L. Lopez-Ribot. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6: 979986.
175. Ramage, G.,, K. VandeWalle,, J. L. Lopez-Ribot, and, B. L. Wickes. 2002. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214: 95100.
176. Rangel-Frausto, M. S.,, T. Wiblin,, H. M. Blumberg,, L. Saiman,, J. Patterson,, M. Rinaldi,, M. Pfaller,, J. E. Edwards, Jr.,, W. Jarvis,, J. Dawson, and, R. P. Wenzel. 1999. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin. Infect. Dis. 29: 253258.
177. Rescigno, M.,, G. Rotta,, B. Valzasina, and, P. Ricciardi-Castagnoli. 2001. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 204: 572581.
178. Rescigno, M.,, M. Urbano,, B. Valzasina,, M. Francolini,, G. Rotta,, R. Bonasio,, F. Granucci,, J. P. Kraehenbuhl, and, P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial mono-layers to sample bacteria. Nat. Immunol. 2: 361367.
179. Rhoads, J. L.,, D. C. Wright,, R. R. Redfield, and, D. S. Burke. 1987. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 257: 31053107.
180. Romagnoli, P.,, N. Pimpinelli,, M. Mori,, P. A. Reichart,, L. R. Eversole, and, G. Ficarra. 1997. Immunocompetent cells in oral candidiasis of HIV-infected patients: an immunohistochemical and electron microscopical study. Oral Dis. 3: 99105.
181. Romani, L. 2002. Immunology of invasive candidiasis, p. 223–241. In R. A. Calderone (ed.), Candida and Candidiasis. ASM Press, Washington, DC.
182. Romano, L. 1996. Biological role of Th cell subsets in candidiasis, p. 114–137. In L. Adorini,, K.-I. Arai,, C. Berek,, J. D. Capra,, A. M. Schmitt-Verhulst, and, B. H. Waksman (ed.), Th1 and Th2 Cells in Health and Disease. Karger, Farmington, CT.
183. Rouabhia, M.,, G. Ross,, N. Page, and, J. Chakir. 2002. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect. Immun. 70: 70737080.
184. Ryckman, C.,, K. Vandal,, P. Rouleau,, M. Talbot, and, P. A. Tessier. 2003. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170: 32333242.
185. Saavedra, M.,, B. Taylor,, N. W. Lukacs, and, P. L. Fidel, Jr. 1999. Local production of chemokines during experimental vaginal candidiasis. Infect. Immun. 67: 58205829.
186. Samonis, G.,, A. Gikas,, P. Toloudis,, S. Maraki,, G. Vrentzos,, Y. Tselentis,, N. Tsaparas, and, G. Bodey. 1994. Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut. Eur. J. Clin. Microbiol. Infect. Dis. 13: 665667.
187. Sangeorzan, J. A.,, S. F. Bradley,, X. He,, L. T. Zarins,, G. L. Ridenour,, R. N. Tiballi, and, C. A. Kauffman. 1994. Epidemiology of oral candidiasis in HIV infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97: 339346.
188. Santoni, G.,, M. Boccanera,, D. Adriani,, R. Lucciarini,, C. Amantini,, S. Morrone,, A. Cassone, and, F. De Bernardis. 2002. Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4 +T cells and possible participation of other local lymphocyte effectors. Infect. Immun. 70: 47914797.
189. Schaller, M.,, R. Mailhammer,, G. Grassl,, C. A. Sander,, B. Hube, and, H. C. Korting. 2002. Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. J. Investig. Dermatol. 118: 652657.
190. Schmid, J.,, F. C. Odds,, M. J. Wiselka,, K. G. Nicholson, and, D. R. Soll. 1992. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J. Clin. Microbiol. 30: 935941.
191. Schuman, P.,, S. Ohmit,, J. D. Sobel,, K. H. Mayer,, V. Greene,, A. Rompalo, and, R. S. Klein. 1998. Oral lesions among women living with or at risk for HIV infection. Am. J. Med. 104: 559563.
192. Schuman, P.,, J. D. Sobel,, S. Ohmit,, K. H. Mayer,, A. Rompalo,, A. Duerr,, D. K. Smith,, D. Warren, and, R. S. Klein. 1998. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection. Clin. Infect. Dis. 27: 11611167.
193. Scott, T. G.,, B. Curran, and, C. J. Smyth. 1989. Electron microscopy of adhesive interactions between Gardnerella vaginalis and vaginal epithelial cells, McCoy cells and human red blood cells. J. Gen. Microbiol. 135: 475480.
194. Shakir, B. S.,, M. V. Martin, and, C. J. Smith. 1981. Induced palatal candidosis in the Wistar rat. Arch. Oral Biol. 26: 787793.
195. Singhi, S.,, D. S. Rao, and, A. Chakrabarti. 2008. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr. Crit. Care Med. 9: 9195.
196. Sobel, J. D. 1988. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544: 547557.
197. Sobel, J. D. 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 14: S148–S153.
198. Sobel, J. D.,, S. Faro,, R. Force,, B. Foxman,, W. J. Ledger,, P. R. Nyirjesy,, B. D. Reed, and, P. R. Summers. 1998. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178: 203211.
199. Sobel, J. D.,, G. Muller, and, H. R. Buckley. 1984. Critical role of germ tube formation in the pathogenesis of candidal vaginitis. Infect. Immun. 44: 576580.
200. Soll, D. R.,, R. Galask,, J. Schmid,, C. Hanna,, K. Mac, and, B. Morrow. 1991. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J. Clin. Microbiol. 29: 17021710.
201. Sonoda, Y.,, N. Mukaida,, J. Wang,, M. Shimada-Hiratsuka,, M. Naito,, T. Kasahara,, A. Harada,, M. Inoue, and, K. Matsushima. 1998. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine. J. Immunol. 160: 61596165.
202. Spellberg, B.,, A. S. Ibrahim,, L. Lin,, V. Avanesian,, Y. Fu,, P. Lipke,, H. Otoo,, T. Ho, and, J. E. Edwards, Jr. 2008. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J. Infect. Dis. 197: 967971.
203. Spinillo, A.,, G. Michelone,, C. Cavanna,, L. Colonna,, E. Capuzzo, and, S. Nicola. 1994. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin. Med. 70: 268272.
204. Steele, C.,, and P. L. Fidel, Jr. 2002. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect. Immun. 70: 577583.
205. Steele, C.,, J. E. Leigh,, R. K. Swoboda, and, P. L. Fidel, Jr. 2000. Growth inhibition of Candida by human oral epithelial cells. J. Infect. Dis. 182: 14791485.
206. Steele, C.,, J. E. Leigh,, R. K. Swoboda,, H. Ozenci, and, P. L. Fidel, Jr. 2001. Potential role for a carbohydrate moiety in anti- Candida activity of human oral epithelial cells. Infect. Immun. 69: 70917099.
207. Steele, C.,, H. Ozenci,, W. Luo,, M. Scott, and, P. L. Fidel, Jr. 1999. Growth inhibition of Candida albicans by vaginal cells from naive mice. Med. Mycol. 37: 251260.
208. Steele, C.,, M. Ratterree, and, P. L. Fidel, Jr. 1999. Differential susceptibility to experimental vaginal candidiasis in macaques. J. Infect. Dis. 180: 802810.
209. Stranford, S. A.,, J. Skurnick,, D. Louria,, D. Osmond,, S. Y. Chang,, J. Sninsky,, G. Ferrari,, K. Weinhold,, C. Lindquist, and, J. A. Levy. 1999. Lack of infection in HIV-exposed individuals is associated with a strong CD8 + cell noncytotoxic anti-HIV response. Proc. Natl. Acad. Sci. USA 96: 10301035.
210. Swidsinski, A.,, W. Mendling,, V. Loening-Baucke,, S. Swidsinski,, Y. Dörffel,, J. Scholze,, H. Lochs, and, H. Verstraelen. 2008. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am. J. Obstet. Gynecol. 198: 97.e91–97.e96.
211. Tachibana, T.,, T. Matsuyama, and, M. Mitsuyama. 1999. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med. Mycol. 37: 397404.
212. Taylor, B. N.,, M. Saavedra, and, P. L. Fidel, Jr. 2000. Local Th1/Th2 cytokine production during experimental vaginal candidiasis. Med. Mycol. 38: 419431.
213. Thompson, G. R., III,, P. K. Patel,, W. R. Kirkpatrick,, S. D. Westbrook,, D. Berg,, J. Erlandsen,, S. W. Redding, and, T. F. Patterson. 2010. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109: 488495.
214. Torres, S. R.,, A. Garzino-Demo,, T. F. Meiller,, V. Meeks, and, M. A. Jabra-Rizk. 2009. Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses 52: 1115.
215. Urban, C. F.,, D. S. M. Ermert,, U. Abu-Abed,, C. Goosman,, W. Nacken,, V. Brinkmann,, P. R. Jungblut, and, A. Zychlinsky. 2009. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 5: e1000639.
216. van der Meijden, W. I.,, H. Koerten,, W. van Mourik, and, W. C. de Bruijn. 1988. Descriptive light and electron microscopy of normal and clue-cell-positive discharge. Gynecol. Obstet. Investig. 25: 4757.
217. Vazquez, J. A.,, J. D. Sobel,, R. Demitriou,, J. Vaishampayan,, M. Lynch, and, M. J. Zervos. 1994. Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J. Infect. Dis. 170: 15661569.
218. Vazquez-Torres, A.,, J. Jones-Carson, and, E. Balish. 1995. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63: 11421144.
219. Villar, C. C.,, H. Kashleva,, C. J. Nobile,, A. P. Mitchell, and, A. Dongari-Bagtzoglou. 2007. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun. 75: 21262135.
220. Vylkova, S.,, N. Nayyar,, W. Li, and, M. Edgerton. 2007. Human beta-defensins kill Candida albicans in an energy-dependent and salt-sensitive manner without causing membrane disruption. Antimicrob. Agents Chemother. 51: 154161.
221. Vylkova, S.,, J. N. Sun, and, M. Edgerton. 2007. The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides. Purinergic Signal 3: 9197.
222. Wagner, R. D.,, C. Pierson,, T. Warner,, M. Dohnalek,, J. Farmer,, L. Roberts,, M. Hilty, and, E. Balish. 1997. Bio-therapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect. Immun. 65: 41654172.
223. Webb, B. C.,, C. J. Thomas,, M. D. Willcox,, D. W. Harty, and, K. W. Knox. 1998. Candida-associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Austral. Dent. J. 43: 160166.
224. Weissenbacher, T. M.,, S. S. Witkin,, A. Gingelmaier,, C. Scholz,, K. Friese, and, I. Mylonas. 2009. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid. Eur. J. Obstet. Gynecol. Reprod. Biol. 144: 5963.
225. Wey, S. B.,, M. Mori,, M. A. Pfaller,, R. F. Woolson, and, R. P. Wenzel. 1989. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch. Intern. Med. 149: 23492353.
226. Wheeler, R. T.,, D. Kombe,, S. D. Agarwala, and, G. R. Fink. 2008. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 4: e1000227.
227. White, M. H. 1996. Is vulvovaginal candidiasis an AIDS-related illness? Clin. Infect. Dis. 22( Suppl. 2) : S124–S127.
228. White, S. J.,, A. Rosenbach,, P. Lephart,, D. Nguyen,, A. Benjamin,, S. Tzipori,, M. Whiteway,, J. Mecsas, and, C. A. Kumamoto. 2007. Self-regulation of Candida albicans population size during GI colonization. PLoS Pathog. 3: e184.
229. Reference deleted.
230. Wisplinghoff, H.,, T. Bischoff,, S. M. Tallent,, H. Seifert,, R. P. Wenzel, and, M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39: 309317.
231. Witkin, S. S. 1986. Inhibition of Candida-induced lymphocyte proliferation by antibody to Candida albicans. Obstet. Gynecol. 68: 696699.
232. Witkin, S. S.,, J. Hirsch, and, W. J. Ledger. 1986. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am. J. Obstet. Gynecol. 155: 790795.
233. Wormley, F. L.,, Jr., J. Chaiban, and, P. L. Fidel, Jr. 2001. Cell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasis. Infect. Immun. 69: 50725079.
234. Wormley, F. L.,, Jr., C. Steele,, K. Wozniak,, K. Fujihashi,, J. R. McGhee, and, P. L. Fidel, Jr. 2001. Resistance of T-cell receptor δ-chain-deficient mice to experimental Candida vaginitis. Infect. Immun. 69: 71627164.
235. Wozniak, K. L.,, J. E. Leigh,, S. Hager,, R. K. Swoboda, and, P. L. Fidel, Jr. 2002. A comprehensive study of Candida-specific antibodies in saliva of HIV-infected persons with oropharyngeal candidiasis. J. Infect. Dis. 185: 12691276.
236. Wozniak, K. L.,, G. Palmer,, R. Kutner, and, P. L. Fidel, Jr. 2005. Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis. Med. Mycol. 43: 589601.
237. Wozniak, K. L.,, F. L. Wormley, Jr., and, P. L. Fidel, Jr. 2002. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect. Immun. 70: 57905799.
238. Wray, D.,, D. H. Felix, and, C. G. Cumming. 1990. Alteration of humoral responses to Candida in HIV infection. Br. Dent. J. 168: 326329.
239. Wuthrich, M.,, B. E. Finkel-Jiminez, and, B. S. Klein. 2000. Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection. Infect. Immun. 68: 71727174.
240. Reference deleted.
241. Yano, J.,, E. Lilly,, M. Barousse, and, P. L. Fidel, Jr. 2010. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect. Immun. 78: 51265137.
242. Yano, J.,, E. Lilly,, C. Steele,, D. Fortenberry, and, P. L. Fidel, Jr. 2005. Oral and vaginal epithelial cell anti- Candida activity is acid-labile and does not require live epithelial cells. Oral Microbiol. Immunol. 20: 199205.
243. Yeater, K. M.,, J. Chandra,, G. Cheng,, P. K. Mukherjee,, X. Zhao,, S. L. Rodriguez-Zas,, K. E. Kwast,, M. A. Ghannoum, and, L. L. Hoyer. 2007. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 153: 23732385.
244. Zelante, T.,, A. De Luca,, P. Bonifazi,, C. Montagnoli,, S. Bozza,, S. Moretti,, M. L. Belladonna,, C. Vacca,, C. Conte,, P. Mosci,, F. Bistoni,, P. Puccette,, R. A. Kastelein,, M. Kopf, and, L. Romani. 2007. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 37: 26802682.
245. Zimmer, D. B.,, E. H. Cornwall,, A. Landar, and, W. Song. 1995. The S100 protein family: history, function, and expression. Brain Res. Bull. 37: 417429.


Generic image for table

Host defenses against mucosal infections

Citation: Fidel, Jr. P, Noverr M. 2012. Mucosal Immunity to , p 137-154. In Calderone R, Clancy C (ed), and Candidiasis, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817176.ch10

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error